Integra Lifesciences Holdings Corp (STU:IL3)
€ 23.8 0.8 (3.48%) Market Cap: 1.83 Bil Enterprise Value: 3.43 Bil PE Ratio: 0 PB Ratio: 1.29 GF Score: 71/100

Integra Lifesciences Holdings Corp at Wells Fargo Healthcare Conference Transcript

Sep 06, 2023 / 05:30PM GMT
Release Date Price: €38.6 (-0.52%)
Vikramjeet Singh Chopra
Wells Fargo Securities, LLC, Research Division - Associate Equity Analyst

Okay. Hello, everyone. My name is Vik Chopra. I'm one of the med tech analysts at Wells Fargo. I'm pleased to introduce the management team from Integra Life Sciences today, joining us as a company are Lea Knight, Integra's new CFO and EVP, and we also have Chris Ward, Senior Director of Investor Relations in the audience. Thanks so much for being here.

Questions & Answers

Vikramjeet Singh Chopra
Wells Fargo Securities, LLC, Research Division - Associate Equity Analyst

So you recently joined Integra. What attracts you to this company. Can you just talk about -- all right, better -- and can you just talk about what changes we can expect from all the metrics that you focus on, how you report, how you guide, et cetera.

Lea Daniels Knight
Integra LifeSciences Holdings Corporation - Executive VP & CFO

Certainly. Good afternoon, everybody. I'm excited to be here, so thank you for the invitation, Vik. So why

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot